D-0686-2021 Class I Ongoing
FDA drug recall D-0686-2021 was initiated by Nuri Trading LLC on Mar 29, 2021 and is designated Class I. Reason for recall: Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil, an FDA approved drug making this an unapproved drug for which the safety and efficacy has not been… The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 28, 2021
- Initiation Date
- Mar 29, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Thumbs Up 7 Black 25K capsule, packaged in a) 1-count blister card and b) 10-count box, Nuri Trading LLC
Reason for recall
Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil, an FDA approved drug making this an unapproved drug for which the safety and efficacy has not been established and therefore subject to recall.
Distribution pattern
USA Nationwide
Code information
all lots within expiry
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0686-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026